Insulin resistance: the shape of things to come. (Q54197369)

26 May 2018

title

Insulin resistance: the shape of things to come. (English)

1 reference

26 May 2018

1 reference

1 reference

B Williams

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 August 1994

1 reference

26 May 2018

published in

The Lancet

1 reference

26 May 2018

volume

344

1 reference

26 May 2018

issue

8921

1 reference

26 May 2018

page(s)

521-524

1 reference

26 May 2018

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

1 reference

7 January 2021

Insulin resistance in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Serum-insulin in essential hypertension and in peripheral vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Racial differences in the relation between blood pressure and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Close correlation of intra-abdominal fat accumulation to hypertension in obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

The relative contribution of body fat and fat pattern to blood pressure level

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

A role for insulin in the aetiology and course of hypertension?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Reduction of blood pressure in obese hyperinsulinaemic hypertensive patients during somatostatin infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Blood pressure reduction in hypertensive-diabetic rats by the somatostatin analog MK-678

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Hyperinsulinaemia is not linked with blood pressure elevation in patients with insulinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Hyperamylinemia, hyperinsulinemia, and insulin resistance in genetically obese LA/N-cp rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Inhibition of insulin secretion, but normal peripheral insulin sensitivity, in a patient with a malignant endocrine pancreatic tumour producing high amounts of an islet amyloid polypeptide-like molecule.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2894%2991904-6

7 January 2021

10.1016/S0140-6736(94)91904-6

Identifiers

DOI

1 reference

26 May 2018

1 reference

26 May 2018